{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:49:43Z","timestamp":1792464583794,"version":"4.5.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:p>\n                    Postmenopausal women with nonalcoholic steatohepatitis are at an increased risk of hepatic fibrosis compared with premenopausal women. Whether duration of estrogen deficiency in postmenopausal state dictates an individual's fibrosis risk remains uninvestigated. We assessed the associations of age at menopause and time from menopause with fibrosis severity in postmenopausal women with nonalcoholic fatty liver disease. Data from 488 postmenopausal women with (1) histologic diagnosis of nonalcoholic fatty liver disease and (2) self\u2010reported information on age at menopause were analyzed. The associations of premature menopause (age at menopause of &lt;40 years) and time from menopause (age at study enrollment \u2010 age at menopause, years) with fibrosis severity (stage 0\u20104) were assessed using multiple ordinal logistic regression models with and without adjusting for clinical confounders. Among the participants (age at menopause 43.7 \u00b1 8.6 years), women with premature menopause (29.3%) were younger at enrollment (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001) and used hormone replacement therapy more often (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.003). After adjusting for age at enrollment, race, waist circumference standardized by body mass index, current smoking, current alcohol use, hypertension, diabetes\/impaired fasting glucose, homeostatic model assessment of insulin resistance, and hormone replacement therapy, premature menopause was associated with an increased likelihood of having more severe fibrosis (adjusted cumulative odds ratio = 1.9, 95% confidence interval 1.3\u20102.7,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.001), while time from menopause was directly associated with an increased likelihood of having more severe fibrosis (adjusted cumulative odds ratio for 5\u2010year unit = 1.2, 95% confidence interval 1.1\u20101.3,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.002).\n                    <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>\n                    : Duration of estrogen deficiency in postmenopausal state confers fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. (H\n                    <jats:sc>epatology<\/jats:sc>\n                    2016;64:85\u201391)\n                  <\/jats:p>","DOI":"10.1002\/hep.28514","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T07:42:54Z","timestamp":1456472574000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":196,"title":["A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease"],"prefix":"10.1097","volume":"64","author":[{"given":"Jagpal Singh","family":"Klair","sequence":"first","affiliation":[{"name":"Department of Medicine,University of Arkansas for Medical Sciences,Little Rock,AR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Dong","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Mayo Clinic College of Medicine,Rochester,MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal F.","family":"Abdelmalek","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology,Duke University,Durham,NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia D.","family":"Guy","sequence":"additional","affiliation":[{"name":"Department of Pathology,Duke University,Durham,NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Gill","sequence":"additional","affiliation":[{"name":"Department of Pathology,University of California San Francisco,San Francisco,CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Yates","sequence":"additional","affiliation":[{"name":"Nonalcoholic Steatohepatitis Clinical Research Network Data Coordinating Center,Johns Hopkins Bloomberg School of Public Health,Baltimore,MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aynur","family":"Unalp\u2010Arida","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases and Nutrition,National Institute of Diabetes and Digestive and Kidney Diseases,National Institutes of Health,Bethesda,MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel E.","family":"Lavine","sequence":"additional","affiliation":[{"name":"Department of Pediatrics,Columbia University,New York,NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne M.","family":"Clark","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine,Department of Medicine,The Johns Hopkins School of Medicine"},{"name":"Department of Epidemiology,The Johns Hopkins Bloomberg School of Public Health,Baltimore,MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Mae","family":"Diehl","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology,Duke University,Durham,NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology,Duke University,Durham,NC"},{"name":"Gastroenterology,Central Arkansas Veterans Healthcare System"},{"name":"Gastroenterology and Hepatology,University of Arkansas for Medical Sciences,Little Rock,AR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Nonalcoholic Steatohepatitis Clinical Research Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,4,5]]},"reference":[{"key":"hep28514-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2217\/17455057.5.2.191","article-title":"Nonalcoholic fatty liver disease in women","volume":"5","year":"2009","journal-title":"Womens Health (Lond Engl)"},{"key":"hep28514-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.33573","article-title":"Nonalcoholic fatty liver disease","volume":"122","year":"2002","journal-title":"Gastroenterology"},{"key":"hep28514-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.26761","article-title":"Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"hep28514-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/hep.27097","article-title":"The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease","volume":"60","year":"2014","journal-title":"Hepatology"},{"key":"hep28514-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/hep.510290307","article-title":"Suppressive effects of estradiol on dimethylnitrosamine\u2010induced fibrosis of the liver in rats","volume":"29","year":"1999","journal-title":"Hepatology"},{"key":"hep28514-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ogc.2011.05.002","article-title":"The timing of the age at which natural menopause occurs","volume":"38","year":"2011","journal-title":"Obstet Gynecol Clin North Am"},{"key":"hep28514-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.maturitas.2009.08.003","article-title":"Premature menopause or early menopause: long\u2010term health consequences","volume":"65","year":"2010","journal-title":"Maturitas"},{"key":"hep28514-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cct.2008.09.003","article-title":"Pioglitazone versus vitamin E versus placebo for the treatment of non\u2010diabetic patients with non\u2010alcoholic steatohepatitis: PIVENS trial design","volume":"30","year":"2009","journal-title":"Contemp Clin Trials"},{"key":"hep28514-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/hep.510370203","article-title":"Nonalcoholic steatohepatitis clinical research network","volume":"37","year":"2003","journal-title":"Hepatology"},{"key":"hep28514-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hep.23784","article-title":"Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"hep28514-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","year":"2005","journal-title":"Hepatology"},{"key":"hep28514-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta\u2010cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","year":"1985","journal-title":"Diabetologia"},{"key":"hep28514-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease\u2010specific mortality in NAFLD after up to 33 years of follow\u2010up","volume":"61","year":"2015","journal-title":"Hepatology"},{"key":"hep28514-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2036.2011.04579.x","article-title":"Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non\u2010alcoholic fatty liver disease","volume":"33","year":"2011","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.28514","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201607000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T19:31:21Z","timestamp":1729193481000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201607000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,5]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.28514","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,5]]},"assertion":[{"value":"2015-09-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-02-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}